Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001346824-26-000041·Eledon Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
ELEDON PHARMACEUTICALS INC COM
Common Stock, $0.001 par value · CUSIP: 28617K101
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- RA Capital Management, L.P.
Shares: 0.00 · Class: 0.0%
- Peter Kolchinsky
Shares: 0.00 · Class: 0.0%
- Rajeev Shah
Shares: 0.00 · Class: 0.0%
- RA Capital Healthcare Fund, L.P.
Shares: 0.00 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001346824-26-000041
- Form type
- SCHEDULE 13G/A
- Filer
- Eledon Pharmaceuticals, Inc.
- CIK
- CIK 1404281
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership